Screener
Jade Biosciences JBIO Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other expense | (9) | — |
| Total other income (expense), net | 3,093 | (14,785) |
| Net loss before income tax expense | (40,352) | (38,169) |
| Income tax expense | (16) | — |
| Net loss | $(40,368) | $(38,169) |
| Other comprehensive income (loss): | ||
| Currency translation adjustment | 2 | — |
| Unrealized loss on investments | (473) | — |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's income tax?
- Jade Biosciences (JBIO) reported income tax of $16K in Q1 2026.
- How has Jade Biosciences's income tax changed year-over-year?
- Jade Biosciences's income tax increased by 10.3% year-over-year, from $14.5K to $16K.
- What is the long-term trend for Jade Biosciences's income tax?
- Over 3 years (2021 to 2025), Jade Biosciences's income tax has grown at a 168.4% compound annual growth rate (CAGR), from $3K to $58K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about Jade Biosciences's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude